Death in Chinese gene-editing trial reported in industry newsletter

A brief item in Stat News's Pharmalittle newsletter (6 August 2026) references a death in a gene-editing trial in China. Genetic Current covered a related development on 6 August — the second child death in the same Chinese investigator-led trial — and on 25 July when the original fatality was first reported. The Pharmalittle mention does not appear to describe a new, separate incident; its language overlaps with reporting on the second child death already published. The item is retained here rather than silently merged because the Stat News newsletter formulation briefly resurfaced the story in a paywall-gated roundup, which may prompt reader queries. No new factual detail beyond that already published is available from the lede text alone. Readers seeking context should refer to the Genetic Current cluster published on 6 August 2026 ('Second child death in Chinese gene-editing trial renews calls for transparency') and the earlier cluster of 25 July 2026.